Jul. 12 at 10:44 PM
🚨
$NBY Why I Picked NBY as our Setup:
I picked NBY because it’s one of the few micro-float plays left with a clean share structure, real catalyst, and asymmetric risk-reward. The company just secured exclusive global rights to a new aesthetic dermatology product via Theravant, aligning with their divestment of Avenova and pivot into higher-margin commercial markets. On top of that, institutional holder Poplar Point Capital filed a fresh 13D confirming an activist stake, showing strong hands are stepping in.
The float is only 5.82M, the chart is breaking out of a multi-month downtrend, and Bollinger Bands are squeezing. Technically, it reclaimed the 0.63–0.64 support zone, and volume confirmed the move with a full float rotation already completed. There’s also speculation of a reverse merger in play and while that's not confirmed, the risk-reward is heavily skewed in favor of bulls if we get a PR.
Add in the gap to
$2.00, which represents nearly 200% upside, and this is one of the most asymmetric trades on the small cap board right now. Just imagine all of that for a minute, will ya?
